Lisinopril dihydrate

This classification denotes an ace inhibitor with the molecular formula C21H31N3O5.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7199S1YWR, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)- but more generally known as lisinopril, which bears US NIH Compound Identifier 5362118. European Medicines Agency schedules Lisinopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08533MIG. World Health Organization schedules lisinopril in its Anatomical Therapeutic Chemical (ATC) Classification. LISINOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule lisinopril dihydrate under HS 29339990 and SITC 51577. SMILES: C1CCC(CC1)CC[C@@H](C(=O)O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O.O.O.